RC9-23210-47811
2 vaccinations
1 coded response
3 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 640 / MO
- Registered
- 2021-01-27
- Relationship
- Self
Timeline
-
2021-01-06
Dose 1 — Pfizer-BioNTech
-
2021-01-27
Registered in v-safe
-
2021-01-27
Dose 2 — Pfizer-BioNTech
-
2021-01-27
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Chills, Fatigue or tirednessAdult check-in
-
2021-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-28
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-31
Survey response — days 1–6 daily, dose 2MedDRA: Hypoaesthesia, Paraesthesia — Feeling: Fair · Site: PainFree text: Numbness & tingling in handsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Pfizer-BioNTech | |
| 2 | 2021-01-27 | Pfizer-BioNTech |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Numbness & tingling in hands
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Hypoaesthesia | ✓ | ✓ | ✓ |
| SRO | Paraesthesia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release